| | | | | | | |
 | JOHNSON & JOHNSON | -2.84% | 7.57% | 3.43% | 7.88% | 27.04% | 479 678 |
| ELI LILLY AND COMPANY | -2.95% | 11.94% | 14.99% | 39.17% | 186.69% | 293 110 |
| PFIZER, INC. | -2.35% | 10.87% | -14.21% | 29.50% | 16.94% | 289 466 |
 | ROCHE HOLDING AG | -1.55% | 5.93% | -16.24% | -7.90% | 16.08% | 272 090 |
| ABBVIE INC. | -0.42% | 10.17% | 12.62% | 34.95% | 109.69% | 269 202 |
 | NOVO NORDISK A/S | -2.64% | 4.43% | 5.31% | 51.47% | 131.46% | 253 053 |
| MERCK & CO., INC. | -2.67% | 10.06% | 19.90% | 19.56% | 9.59% | 235 508 |
| NOVARTIS AG | -1.10% | 3.01% | 1.07% | -4.16% | -9.05% | 183 371 |
| BRISTOL-MYERS SQUIBB COMPANY | -1.60% | 7.04% | 26.22% | 18.52% | 73.54% | 168 111 |
 | SANOFI | -0.22% | 6.79% | 12.18% | 12.60% | 31.30% | 132 461 |
| AMGEN INC. | -0.55% | 4.54% | 8.24% | 0.28% | 32.14% | 131 077 |
 | GSK PLC | 0.42% | 4.18% | 10.27% | 25.36% | 11.98% | 109 224 |
 | BAYER AG | 1.40% | -7.61% | 28.15% | 16.30% | -1.04% | 59 888 |
 | DAIICHI SANKYO CO., LTD. | 2.95% | 8.95% | 16.96% | 39.92% | 82.10% | 46 990 |
| CHUGAI PHARMACEUTICAL CO., LTD | 0.36% | 7.91% | -3.91% | -19.20% | 54.26% | 43 454 |
| | | | | | | |
| | Durchschnitt | -0.92% | 6.39% | 8.33% | 17.62% | 51.52% | |
| | Gewichteter Durchschnitt nach Marktkapitalisierung | -1.69% | 7.45% | 5.96% | 19.39% | 56.81% | |
English (USA)
English (UK)
English (Canada)
Deutsch (Deutschland)
Español
Français (France)
Italiano
Nederlands (Nederland)
Nederlands (België)
Bericht
